Image

Community Safety and Violence

Community Safety and Violence

Recruiting
All
Phase N/A

Powered by AI

Overview

This study will describe, estimate, and explore the effectiveness of community-centered safety models (CCSMs)-including co-response, alternative response, and community violence intervention modalities-implemented across U.S. municipalities to prevent community violence among youth and young adults (YYA). Specifically, the investigators will (1) describe CCSM implementation using implementation-science methods, (2) estimate CCSMs' impacts on community-violence outcomes using quasi-experimental methods, and (3) explore operational and contextual factors associated with stronger or weaker effects.

Eligibility

Inclusion Criteria for Jurisdiction/Sites:

  1. Intervention modality clarity: A single, identifiable CCSM-Co-Response (CRM), Alternative Response (ARM), or Community Violence Intervention (CVI)-implemented at city/county level.
  2. Documented launch date \& scope: Public or official documentation specifying program start date, catchment, operating hours, staffing, eligibility, and core activities.
  3. Observation window: ≥24 months pre-implementation and ≥12 months post-implementation of outcome data (monthly preferred; annual acceptable for fatal outcomes).
  4. Outcomes coverage: Availability of primary outcomes (fatal and nonfatal violent injury) and at least one secondary justice outcome at the jurisdiction level.
  5. Data quality: Stable geographic boundaries, consistent reporting practices, and no catastrophic breaks that preclude credible counterfactual fit.
  6. Donor comparability: Jurisdiction characteristics and data cadence compatible with a pooled augmented synthetic control design (i.e., can be matched to a synthetic control and included in permutation tests).

Exclusion Criteria:

  1. Pilot-only or indeterminate programs: Short-lived pilots, ambiguous or multi-modality rollouts where treatment timing or content cannot be reliably defined.
  2. Severe data discontinuity: Major boundary changes, reporting suspensions, coding overhauls, or dataset gaps that undermine time-series integrity (e.g., prolonged outages during system migration) and cannot be addressed with standard remedies.
  3. Overlapping major interventions: Concurrent, poorly measured citywide initiatives (e.g., sweeping policy bundles) that coincide with the CCSM start and make identification infeasible.
  4. Insufficient pre-period: \<24 months pre-implementation data for primary outcomes.
  5. Incompatible cadence/aggregation: Outcomes only available at spatial or temporal units that cannot be aligned with other sites or donors.

Study details
    Community-Centered Safety

NCT07494019

NYU Langone Health

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.